Previously, the treatment for resectable pancreatic ductal carcinoma was surgery, followed by adjuvant chemotherapy. In 2008, a large retrospective study showed that adjuvant treatment of neoplasia after surgery had a survival advantage over preoperative surgery with or without adjuvant therapy, suggesting the role of adjuvant therapy. adjuvant neoplasia in the treatment of reversible pancreatic ductal carcinoma.